Press release
Global Gonorrhea Testing Market
Gonorrhea is one of the very common sexually transmitted disease (STD), which is basically an inflammation on mucous membrane surface caused by microorganism Neisseria gonorrhoeae. The infection can affect both men and women. In women, the infection grows in moist & warmth area of reproductive track including uterus, cervix, and fallopian tube. The infection also grows in mouth, throat, urethra and anus, in both men and women. Most of the times, many men and women does not develop any noticeable symptoms of gonorrhea. Whenever the infected person develop any symptoms, it tends to be similar to the other bacterial infection, which makes it difficult to identify the gonorrhea infection. Few of the mild symptoms of gonorrhea includes discharge from vagina and penis, frequent urine discharge, burning sensation while urinating, and less commonly swollen testicles. The gonorrhea infection can spread through intercourse, and anal or oral sex. In around ninety percent of oral infection, there are no visible infection apart from sore throat, itchiness, which is most common in any other bacterial infection.A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/14404
According to CDC, around 820,000 new cases of gonorrhea are estimated to found in the U.S. each year, and is reported to be the most commonly occurred communicable disease among young population. Among these 820,000 new cases, 70% of population are expected to age between 15 to 24 years. CDC stated, women aged 25 and above are at the higher risk of gonorrhea infection. The risk factors for gonorrhea includes unprotected sex, multiple sex partners, and oral or anal sex with STI infected person. The diagnosis of gonorrhea infection involves several ways, however, the most common method includes fluid sample from infected area i.e. penis, vagina, throat or rectum, with as swab. Sometimes, blood samples are require to diagnose the infection. After sample collection, certain stains are added to the sample and the stain reaction would then diagnose the infection. This method is most commonly adopted as it is quick and easy, however, it might not provide absolute certainty. Other diagnosis method includes cell culture, which includes sample placement in petri dish, and incubate under growth conditions. If gonorrhea infection is present in the given sample, then a colony of gonorrhea bacteria would grow in the petri dish, and the infection can be diagnose.
Gonorrhea testing market is expected to witness exponential growth attributed to increasing involvement of multiple sex partners and changing lifestyle would significantly boosted the market for gonorrhea testing. According to CDC, the gonorrhea infection/bacteria are being resistant to strains in patients, thus, it further exaggerates the demand for gonorrhea diagnostic testing. On the other hand, the high cost associated with the gonorrhea diagnostic test is likely to hinder the market growth to some extent. Additionally, reluctant attitude of patients towards the diagnosis and medication couples with the discontinuation of assigned therapies would restrain the market growth.
Gonorrhea testing market is classified on the basis of test type, sample type, end user, and geography.
Based on test type, the market is segmented into nucleic acid amplification (NAA), gram stain, Enzyme-linked immunosorbent assay (ELISA), gonorrhea culture and rapid test. Among these, Enzyme-linked immunosorbent assay (ELISA) is one of the highest adopted test for the detection of gonorrhea. The increasing use of ELISA test is key trend in this market owing to its high efficiency, level of accuracy, and reliability on the performed tests. Moreover, the advancement in the sexually transmitted disease diagnosis plays a vital role in the development of reliable tests for gonorrhea.
Based on geography, the market is segmented into North America, Latin America, Europe, Asia-pacific and MEA. The market is majorly driven by developed economies owing to the large patient base suffering from gonorrhea, high awareness regarding disease and associated symptoms and high diagnostic rate of sexually transmitted disease. On the other hand, the knowledge of sexually transmitted disease is limited in developing and underdeveloped economies. However, the increasing incidence of STDs and growing government initiatives regarding the awareness of sexually transmitted disease would drive the market growth. In addition, the introduction of government reforms for the improvement of healthcare infrastructure, more focused on the emerging countries is expected to drive the gonorrhea diagnostic market growth over the forecast period.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/14404
Some of the key participating global players in gonorrhea testing market are Abbott Laboratories, Bayer AG, Merck and Company Inc., Agilent Technologies, Biomerieux, Danaher Corporation, Thermo Fisher Scientific, Alere Inc., DiaSorin, Bristol-Myers Squibb, and F. Hoffmann-La Roche AG.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gonorrhea Testing Market here
News-ID: 488299 • Views: …
More Releases from Persistence Market Research Pvt. Ltd

Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size
The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032.
The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation…

Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers
The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism.
Stay Ahead with Market Intelligence Get Free…

Predictive Insights for Precision Medicine: The Global Biosimulation Market is S …
Biosimulation Market Research
The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.
Market Overview
The biosimulation market has experienced rapid growth…

Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market
The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing.
Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961
The global wheelchair and components market has witnessed significant growth in…
More Releases for Gonorrhea
Gonorrhea - Drug Pipeline Landscape, 2022
Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. Gonorrhea most often affects the urethra, r*ctum or throat. In females, gonorrhea can also infect the cervix. Symptoms of Gonorrhea infection in men include painful urination, pain or swelling in one t*sticle and in women include increased vaginal discharge, painful urination, vaginal bleeding between periods and abdominal or pelvic pain. Diagnosis of Gonorrhea can be done after…
Gonorrhea Diagnostics Market Information - Forecast To 2023
Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of…
Global Gonorrhea Diagnostics Sales Market Report 2017
Global Gonorrhea Diagnostics Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020.
The report on the global Gonorrhea Diagnostics market deals with the all its critical details with the help of an in-depth and insightful analysis. The market is explained in an all-inclusive manner and therefore allows the report to present a complete analysis of the market as devised using…
Global Gonorrhea Diagnostics Market Research Report 2017
Global Gonorrhea Diagnostics Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020.
A new research report on the global Gonorrhea Diagnostics market offers a 360-degree overview of it. The report discusses the market in significant details and elucidates all aspects of the global Gonorrhea Diagnostics market likely to impact its growth trajectory in the upcoming years. Major market stimulants and…
Global Gonorrhea Diagnostics Market Research Report 2017
This report studies Gonorrhea Diagnostics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
Agilent Technologies
Alere
Becton Dickinson and Company
F.Hoffmann-La Roche AG
Tosoh Corporation
PerkinElmer,Inc
Bio-Rad
Request Sample Report:
http://www.reportbazzar.com/request-sample/?pid=888233&ptitle=Global+Gonorrhea+Diagnostics+Market+Research+Report+2017&req=Sample
Cepheid
Diamedix
Kyowa Medex
Lonza
Mackay Life Sciences
Nihon Kohden
Ortho Clinical Diagnostics
Polymedco
Qiagen
SDIX
Sequenom
Sienco
Sysmex
Takara Bio
Market Segment by Regions, this report splits Global into several key Regions, with production,…
Gonorrhea Diagnostic Market — Global Industry Insights 2024
Ease of Testing: Can be done on non-invasive and self-collected specimens
Sexually transmitted Diseases (STDs) are one of the leading health problems globally, affecting the quality of life and triggering serious morbidity and mortality. Gonorrhea is the most common among the various sexually transmitted diseases with the age group of 15 to 24 years being the largest affected group. Around 350,062 gonorrhea cases were reported in the U.S. in 2014, with…